Skip to content

Gallbladder Functions & Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum

Gallbladder Functions & Serum Cholecystokinin Levels in Pregnant Women Diagnosed With Hyperemesis Gravidarum

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03950167
Enrollment
325
Registered
2019-05-15
Start date
2019-03-26
Completion date
2020-05-15
Last updated
2021-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperemesis Gravidarum, Pregnancy Related

Keywords

gallbladder functions, cholecystokinin, hyperemesis gravidarum

Brief summary

This study evaluates the gallbladder functions and serum cholecystokinin levels in pregnant women diagnosed with hyperemesis gravidarum. Half of the participants are healthy pregnant women and half of the participants are pregnant women diagnosed with hyperemesis gravidarum. Two groups will be compared by means of gallbladder functions and serum cholecystokinin levels.

Detailed description

Previously gallbladder functions have been observed in human with gallbladder disease. However it has never been evaluated whether there is any difference in gallbladder functions between healthy pregnant women and pregnant women diagnosed with hyperemesis gravidarum. Moreover correlation between hyperemesis gravidarum symptom scores and gallbladder functions has never been assessed. There is also few data comparing serum cholecystokinin levels between healthy pregnant women and those diagnosed with hyperemesis gravidarum. The investigators will measure serum cholecystokinin levels after a fatty meal (100 g chocolate) and compare two groups. In this study the investigators would like to evaluate gallbladder functions and serum cholecystokinin levels in women with hyperemesis gravidarum and compare these with healthy subjects.

Interventions

None listed

Sponsors

Müge Keskin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* gestation week between 6 and 14 weeks, * singleton pregnancy with a live embryo, * healthy women without any medical disorders,

Exclusion criteria

* any systemic disease, * gallbladder disease * any psychological disorder that can cause vomiting, * multiple gestation

Design outcomes

Primary

MeasureTime frameDescription
Blood Cholecystokinin (CCK) LevelsFasting (baseline) and postprandial (15 minutes after the test meal) CCK levela gut hormone released, its level can be measured in blood as fasting level and postprandial
Gallbladder (GB) Wall Thicknessfasting and postprandial 45th minuteGB wall thickening measured with abdominal ultrasound at fasting and postprandial
Gallbladder (GB) Volumefasting and postprandial 45th minutevolume of GB measured with abdominal ultrasound at fasting and postprandial
Gallbladder (GB) Ejection FractionThe fasting and postprandial 45th minuteGB ejection fraction measures how much bile gallbladder releases at one time, expressed as percentage

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

This is a prospective cohort study conducted in Ufuk University hospital, Ankara, Turkey (a tertiary center) between March 2019 and May 2020.

Pre-assignment details

Excluded (n=275) * Not meeting inclusion criteria (n=163) Inclusion criteria were: gestation week between 6 and 14 weeks, singleton pregnancy with a live embryo, age range between 18 and 40 years, healthy women without any medical disorders, Women with any systemic disease, gallbladder disease or any psychological disorder that can cause vomiting, multiple gestation were excluded. * Declined to participate (n=112)

Participants by arm

ArmCount
Hyperemesis Gravidarum
pregnant women before 14 weeks of pregnancy diagnosed with hyperemesis gravidarum will be assessed in terms of gallbladder functions and serum cholecystokinin levels after a fatty meal.
24
Healthy Pregnant Women
Healthy pregnant women before 14 weeks of pregnancy without hyperemesis gravidarum will be assessed in terms of gallbladder functions and serum cholecystokinin levels after a fatty meal.
22
Total46

Baseline characteristics

CharacteristicHealthy Pregnant WomenHyperemesis GravidarumTotal
age30.08 years
STANDARD_DEVIATION 4.03
30.91 years
STANDARD_DEVIATION 4.2
30.49 years
STANDARD_DEVIATION 4.11
Age, Continuous30.91 years
STANDARD_DEVIATION 4.2
30.08 years
STANDARD_DEVIATION 4.03
30.49 years
STANDARD_DEVIATION 2.11
body mass index (BMI)24.55 kg/m²
STANDARD_DEVIATION 4.72
23.95 kg/m²
STANDARD_DEVIATION 3.53
24.25 kg/m²
STANDARD_DEVIATION 4.125
Gestational age8.92 weeks9.07 weeks8.995 weeks
gravidity2 gravidity2 gravidity2 gravidity
parity1 parity1 parity1 parity
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
22 Participants24 Participants46 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Turkey
22 participants24 participants46 participants
Sex: Female, Male
Female
22 Participants24 Participants46 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 22
other
Total, other adverse events
0 / 240 / 22
serious
Total, serious adverse events
0 / 240 / 22

Outcome results

Primary

Blood Cholecystokinin (CCK) Levels

a gut hormone released, its level can be measured in blood as fasting level and postprandial

Time frame: Fasting (baseline) and postprandial (15 minutes after the test meal) CCK level

ArmMeasureGroupValue (MEAN)Dispersion
Hyperemesis GravidarumBlood Cholecystokinin (CCK) Levelsfasting CCK53.13 picogram/mililiters (pg/ml)Standard Deviation 25.3
Hyperemesis GravidarumBlood Cholecystokinin (CCK) Levelspostprandial CCK73.61 picogram/mililiters (pg/ml)Standard Deviation 30.29
Healthy Pregnant WomenBlood Cholecystokinin (CCK) Levelsfasting CCK54.55 picogram/mililiters (pg/ml)Standard Deviation 25.32
Healthy Pregnant WomenBlood Cholecystokinin (CCK) Levelspostprandial CCK81.24 picogram/mililiters (pg/ml)Standard Deviation 29.89
p-value: 0.05t-test, 2 sided
Comparison: Since this is the first study comparing both CCK levels and GB functions in patients diagnosed with hyperemesis gravidarum (HG) and healthy pregnant women, a power analysis was not feasible.p-value: 0.05t-test, 2 sided
Primary

Gallbladder (GB) Ejection Fraction

GB ejection fraction measures how much bile gallbladder releases at one time, expressed as percentage

Time frame: The fasting and postprandial 45th minute

ArmMeasureValue (MEAN)Dispersion
Hyperemesis GravidarumGallbladder (GB) Ejection Fraction52.06 Percantage (%)Standard Deviation 19.45
Healthy Pregnant WomenGallbladder (GB) Ejection Fraction45.46 Percantage (%)Standard Deviation 16.59
p-value: 0.05t-test, 2 sided
p-value: 0.05t-test, 2 sided
Primary

Gallbladder (GB) Volume

volume of GB measured with abdominal ultrasound at fasting and postprandial

Time frame: fasting and postprandial 45th minute

ArmMeasureGroupValue (MEAN)Dispersion
Hyperemesis GravidarumGallbladder (GB) Volumefasting GB volume36.9 mililiter (ml)Standard Deviation 13.8
Hyperemesis GravidarumGallbladder (GB) Volumepostprandial GB volume17.29 mililiter (ml)Standard Deviation 8.14
Healthy Pregnant WomenGallbladder (GB) Volumefasting GB volume33.69 mililiter (ml)Standard Deviation 12.54
Healthy Pregnant WomenGallbladder (GB) Volumepostprandial GB volume18.33 mililiter (ml)Standard Deviation 6.98
p-value: 0.05t-test, 2 sided
p-value: 0.05t-test, 2 sided
Primary

Gallbladder (GB) Wall Thickness

GB wall thickening measured with abdominal ultrasound at fasting and postprandial

Time frame: fasting and postprandial 45th minute

ArmMeasureGroupValue (MEAN)Dispersion
Hyperemesis GravidarumGallbladder (GB) Wall Thicknessfasting GB wall thickness2.10 milimeters (mm)Standard Deviation 0.57
Hyperemesis GravidarumGallbladder (GB) Wall Thicknesspostprandial GB wall thickness2.51 milimeters (mm)Standard Deviation 0.51
Healthy Pregnant WomenGallbladder (GB) Wall Thicknessfasting GB wall thickness2.11 milimeters (mm)Standard Deviation 0.47
Healthy Pregnant WomenGallbladder (GB) Wall Thicknesspostprandial GB wall thickness2.74 milimeters (mm)Standard Deviation 0.76
p-value: 0.05t-test, 2 sided
p-value: 0.05t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026